This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why Is Colgate-Palmolive (CL) Down 9.1% Since its Last Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Lockheed Martin, Mastercard, Colgate, Electronic Arts and McKesson
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Lockheed Martin, Mastercard, Colgate, Electronic Arts and McKesson
Will New Products Lift Procter & Gamble's (PG) Q2 Sales?
by Zacks Equity Research
Soft consumer-spending environment and higher competition in developed markets might hurt Procter & Gamble's (PG) Q2 sales. However, new product launches are likely to offset the negatives.
5 Reasons Why Clorox (CLX) is a Must Add Stock Right Now
by Zacks Equity Research
The Clorox Inc. (CLX) stock has been moving up the charts, thanks to the smooth execution of its 2020 strategy. By its actions, the company is poised to boost growth for its categories as well as overall market share.
Colgate (CL) Q3 Earnings in Line, Sales Beat, Stock Down
by Zacks Equity Research
Colgate (CL) came out with third-quarter 2017 adjusted earnings of 73 cents per share, which came in line with Zacks Consensus Estimate.
Will V.F. Corp (VFC) Strategies Facilitate Q3 Earnings Beat?
by Zacks Equity Research
We expect the designer, manufacturer and marketer of branded apparel and related products, V. F. Corporation (VFC) to beat expectations when it reports third-quarter 2017 results on Oct 23.
Will Colgate's Strategic Initiatives Help Counter Sales Woes?
by Zacks Equity Research
Colgate-Palmolive (CL) remains committed to its savings programs with a disciplined capital strategy. However, the company has a dismal sales trend.
Clorox's (CLX) Long-Term Strategy Bode Well: Here's Why
by Zacks Equity Research
The Clorox Company (CLX) remains keen on the smooth execution of its 2020 Strategy, which is aimed at boosting growth for the improvement of categories and overall market share.
Colgate (CL) Dips Despite In-Line Q2 Earnings, Sales Lag
by Zacks Equity Research
Despite in-line earnings, Colgate-Palmolive Co. (CL) shares dipped 2.3% in pre-market trading hours, due to skepticism on its top-line performance and soft organic sales view.
Colgate (CL) Q2 Earnings in Line, Stock Down on Sales Miss
by Zacks Equity Research
Colgate-Palmolive (CL) came out with second-quarter 2017 results, wherein sales continued to lag estimates, leading to a revised outlook.
Church & Dwight (CHD) Shares Up on Water Pik Buyout Talks
by Zacks Equity Research
The acquisition of Water Pik will complement and expand Church & Dwight's (CHD) oral care portfolio.
3 Consumer Staples Stocks With Strong Growth Prospects
by Zacks Equity Research
Our research shows that stocks with Growth Style Score of A or B when combined with a Zacks Rank #1 (Strong Buy) or 2 (Buy) offer the best investment opportunities in the growth investing space and certainly have bright prospects to ride out the impending volatility.
What Makes Colgate-Palmolive (CL) a Treasured Holding?
by Zacks Equity Research
Investors of the leading consumer products company, Colgate-Palmolive Company (CL) will agree to the fact that this stock has never let them down.
Colgate-Palmolive (CL) Up 2.9% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Colgate-Palmolive (CL) In Focus: Stock Adds 5.7% in Session
by Zacks Equity Research
Colgate-Palmolive Company (CL) moved big last session, as its shares jumped almost 6% on the day.
Top Research Reports for Today: MA, CVS, CL & More
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including MasterCard (MA), CVS Health (CVS) and Colgate-Palmolive (CL).
What's in Store for Reynolds American (RAI) in Q1 Earnings?
by Zacks Equity Research
Reynolds American, Inc. (RAI) is set to report first-quarter 2017 results before the opening bell on May 3.
Colgate (CL) Beats on Q1 Earnings, Stock Down on Sales Miss
by Zacks Equity Research
Colgate-Palmolive Co. (CL), a global dealer in consumer goods, came out with first-quarter 2017 adjusted earnings of 67 cents per share surpassed the Zacks Consensus Estimate by a penny.
Procter & Gamble (PG) Tops Q3 Earnings Estimates, Sales Dip
by Zacks Equity Research
The Procter & Gamble Company (PG), popularly known as P&G, reported third-quarter fiscal 2017 financial results, wherein earnings exceeded expectations, while revenues missed the same.
Top Research Reports for Today: JNJ, VZ, V
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Verizon (VZ), and Visa (V).
The Zacks Analyst Blog Highlights: ExxonMobil, Colgate-Palmolive, Honeywell, Verizon and United Technologies
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ExxonMobil, Colgate-Palmolive, Honeywell, Verizon and United Technologies
The Zacks Analyst Blog Highlights: ConocoPhillips, Colgate-Palmolive, Vale, State Street and Bayer
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ConocoPhillips, Colgate-Palmolive, Vale, State Street and Bayer
Top Research Reports for Vale, ConocoPhillips & Colgate-Palmolive
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including ConocoPhillips (COP), Colgate-Palmolive (CL), and Vale (VALE).
Top Research Reports for Netflix, Goldman Sachs & Kinder Morgan
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), Kinder Morgan Inc (KMI) and The Goldman Sachs Group Inc (GS).
Top Research Reports on Wells Fargo, Altria and Dow
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), Altria (MO) and Dow Chemical (DOW).